Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × Oxaliplatin × Clear all

NCT05564377 2026-06-02

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Phase 2 Recruiting

2,900 enrolled

Gynecologic

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

NCT05007106 2025-08-14

KEYVIBE-005

Phase 2 Completed

613 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT00071929 2013-06-24

Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer

Phase 2 Completed

Gynecologic

Endometrial Neoplasms

NCT00612495 2008-02-11

Endometrial Cancer - LOHP Alone and With 5FU

Phase 2 Completed

31 enrolled

Gynecologic

Endometrial Neoplasms